BRAINSTORM CELL THERAPEUTICS INC. Accounts Payable, Other, Current
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Accounts Payable, Other, Current of $694.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes
us-gaap:AccountsPayableOtherCurrent · last filed 2019-05-10
- 2019-03-31: Accounts Payable, Other, Current $694.00K.
- 2018-12-31: Accounts Payable, Other, Current $622.00K.
- 2018-09-30: Accounts Payable, Other, Current $631.00K.
- 2018-06-30: Accounts Payable, Other, Current $609.00K.
| Period end | Accounts Payable, Other, Current | Accounts Payable, Other, Current as first filed |
|---|---|---|
| 2019-03-31 | $694.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $622.00K 10-Q · filed 2019-05-10 | |
| 2018-09-30 | $631.00K 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $609.00K 10-Q · filed 2018-07-23 | |
| 2018-03-31 | $674.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $677.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $411.00K 10-Q · filed 2017-10-17 | |
| 2017-06-30 | $370.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $337.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $367.00K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $267.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $275.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $286.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $283.00K 10-K · filed 2017-03-29 | |
| 2015-09-30 | $195.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $266.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $233.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $224.00K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $275.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $270.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $247.00K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $227.00K 10-K · filed 2015-03-26 | |
| 2013-09-30 | $230.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $221.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $159.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $193.00K 10-K · filed 2014-03-27 | $176.00K 10-K · filed 2013-03-14 |
| 2012-09-30 | $73.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $145.00K 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | $126.00K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $141.00K 10-K · filed 2013-03-14 | |
| 2011-09-30 | $94.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $385.00K 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | $531.00K 10-K · filed 2012-03-15 | $471.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |